Hester Biosciences Ltd Share Price Hester Bios

1,660.10

Open ()
Turnover (lac)
Prev. Close ()
Day's Vol.(shares)

1,659.60

Open ()
Turnover (lac)
Prev. Close ()
Day's Vol.(shares)
Detailed Quote

Corporate Action

Period From
Period To
Purpose AGM Date Announcement Date Book Closure Start Date Book Closure End Date
Board Meeting - 18-Jul-2019 - -
HESTER BIOSCIENCES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/07/2019 ,inter alia, to consider and approve the Standalone and Consolidated Unaudited Financial Results for the quarter ended on 30 June 2019 Outcome of Board Meeting held today and Submission of Standalone and Consolidated Unaudited Financial Results for the quarter ended on 30 June 2019 (As Per BSE Announcement Dated On 31/07/2019)
Board Meeting - 29-Apr-2019 - -
Hester Biosciences Ltd has informed BSE that a Meeting of the Board of Directors of the Company will be held on May 07, 2019, to consider the Audited Standalone and Consolidated Financial Results for the quarter and year ended on March 31, 2019 and to consider declaration of the final dividend, if any, on the equity shares of the Company, for the financial year 2018-19. The Board of Directors recommended final dividend of 70% that is INR 7.00 per equity share for the financial year 2018-19, subject to approval of members in the ensuing Annual General Meeting. Outcome of Board Meeting held today and Submission of Audited Standalone and Consolidated Financial Results for the quarter and year ended on 31 March 2019 The Board of Directors recommended final dividend of 70% that is INR 7.00 per equity share for the financial year 2018-19, subject to approval of members in the ensuing Annual General Meeting. (As Per BSE Announcement Dated on 07.05.2019)
Board Meeting - 21-Jan-2019 - -
HESTER BIOSCIENCES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/01/2019 ,inter alia, to consider and approve Unaudited Standalone Financial Results for the quarter and nine months ended on 31 December 2018 Board of Directors, in their Meeting held today, have approved the Unaudited Standalone Financial Results for the quarter and nine months ended on 31 December 2018. (As Per BSE Announcement Dated On 29/01/2019)
Board Meeting - 17-Oct-2018 - -
Hester Biosciences Ltd has informed BSE that a Meeting of the Board of Directors of the Company will be held on October 29, 2018 to consider the Unaudited Standalone Financial Results for the quarter and half year ended September 30, 2018 and to consider declaration of second interim dividend, if any, on the equity shares of the Company, for the financial year 2018-19.Further, in compliance with SEBI (Prohibition of Insider Trading) Regulations, read with code of conduct of the Company, the Trading Window for dealing in equity shares of the Company shall remain closed from October 17, 2018 and will end 48 hours after the financial results are made public on October 29, 2018. Pursuant to the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that Board of Directors, in their Meeting held today, have approved the followings: 1.Unaudited Standalone Financial Results for the quarter and half year ended on 30 September2018. 2.The Board of Directors declared 2nd interim dividend of 20% that is INR 2.00 (two) per equityshare on the face value of INR 10 (ten) per share. The Company has already paid 1st InterimDividend of INR 2.00 (Two) per equity shares. 3.Revision in remuneration of Mr. Rajiv Gandhi, CEO & Managing Director of the Company forthe current tenure ending on 31 March 2020, subject to approval of Members. Pursuant to the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that Board of Directors, in their Meeting held today, have approved the followings: 1. Unaudited Standalone Financial Results for the quarter and half year ended on 30 September 2018. 2. The Board of Directors declared 2nd interim dividend of 20% that is INR 2.00 (two) per equity share on the face value of INR 10 (ten) per share. The Company has already paid 1st Interim Dividend of INR 2.00 (Two) per equity shares. 3. Revision in remuneration of Mr. Rajiv Gandhi, CEO & Managing Director of the Company for the current tenure ending on 31 March 2020, subject to approval of Members. The Board of Directors declared 2nd interim dividend of 20% that is INR 2.00 (two) per equity share on the face value of INR 10 (ten) per share. The Company has already paid 1st Interim Dividend of INR 2.00 (Two) per equity shares. The Board of Directors declared 2nd interim dividend of 20% that is INR 2.00 (two) per equity share on the face value of INR 10 (ten) per share. The Company has already paid 1st Interim Dividend of INR 2.00 (Two) per equity shares. Regulation 42 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, the Record Date is Monday, 12 November 2018 for the purpose of 2nd interim dividend of INR 2.00 (two) per equity share of the Company for the financial year 2018-19, as declare by the Board of Directors at their meeting held on Monday, 29 October 2018. (As Per BSE Announcement Dated on 29.10.2018)